Exane Derivatives’s VF Corp VFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,821
Closed -$217K 976
2022
Q1
$217K Buy
+3,821
New +$237K 0.06% 309
2021
Q4
Sell
-9,371
Closed -$628K 1028
2021
Q3
$628K Buy
9,371
+104
+1% +$7.98K 0.15% 145
2021
Q2
$758K Buy
9,267
+8,604
+1,298% +$717K 0.17% 112
2021
Q1
$53K Buy
663
+247
+59% +$20K 0.02% 510
2020
Q4
$35.5K Buy
+416
New +$33.2K 0.01% 483
2016
Q4
Sell
-14,122
Closed -$745K 685
2016
Q3
$745K Buy
14,122
+9,239
+189% +$533K 0.11% 126
2016
Q2
$283K Buy
4,883
+2,092
+75% +$124K 0.05% 177
2016
Q1
$170K Sell
2,791
-551
-16% -$32K 0.02% 205
2015
Q4
$196K Buy
3,342
+1,837
+122% +$115K 0.03% 161
2015
Q3
$96.6K Sell
1,505
-1,034
-41% -$70.8K 0.01% 233
2015
Q2
$167K Buy
+2,539
New +$172K 0.02% 220

Other funds holding VFC

Exane Derivatives's VFC Position: Q2 2022 in Review

Exane Derivatives sold out of VF Corp (VFC) in Q2 2022, closing a stake of 3,821 shares — an estimated $217K sold.

Exane Derivatives first reported a position in VFC in Q2 2015 and held it in 11 quarters. The position peaked at $758K in Q2 2021. 818 funds tracked by Wall St. Rank hold VFC as of Q2 2022.

  • Exane Derivatives reported no remaining VF Corp position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 3,821 VF Corp shares in Q2 2022, an estimated $217K.
  • Exane Derivatives first reported a position in VF Corp in Q2 2015 and held it in 11 quarters.
  • Exane Derivatives's VF Corp position peaked at $758K in Q2 2021.
  • 818 funds tracked by Wall St. Rank held VF Corp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.